Direct economic burden of high-risk and metastatic melanoma in the elderly: Evidence from the SEER-medicare linked database

Applied Health Economics and Health Policy

Volumn 7, Issue 1, 2009, Pages 31-41

  Davis, Keith L ^a   Mitra, Debanjali ^a   Kotapati, Srividya ^b   Ibrahim, Ramy ^b   Wolchok, Jedd D ^c  

^a RTI HEALTH SOLUTIONS   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; DATA BASE; DEATH; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICARE; MELANOMA; UNITED STATES;

AGED; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; LEAST-SQUARES ANALYSIS; MALE; MEDICARE; MELANOMA; NEOPLASM METASTASIS; NEOPLASM STAGING; SEER PROGRAM; UNITED STATES;

EID: 70349118203     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/bf03256140     Document Type: Article

References (23)

1. American Cancer Society (ACS). Cancer facts and figures 2007. Atlanta (GA): American Cancer Society, 2007
2. Goldstein BG, Goldstein AO. Diagnosis and management of malignant melanoma. Am Fam Physician 2001; 63 (7): 1359-1368
3. Lachiewicz AM, Berwick M, Wiggins CL, et al. Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. J Invest Dermatol 2008; 128 (5): 1340-1342
4. Dale PS, Foshag LJ,Wanek LA, et al. Metastasis of primary melanoma to two separate lymph node basins: prognostic significance. Ann Surg Oncol 1997; 4 (1): 13-18
5. Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 2007; 82 (4): 490-513
6. Hillner BE, Kirkwood JM, Agarwala SS. Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases. Cancer 2001; 91 (9): 1814-1821
7. Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol 1998; 38 (5 Pt 1): 669-680
8. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002a; 40 (8 Suppl.): IV3-18
9. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol 1997; 50 (8): 939-945
10. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEERMedicare data to identify chemotherapy use. Med Care 2002b; 40 (8 Suppl.): IV55-61
11. Virnig BA, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare linked data. Med Care 2002; 40 (8 Suppl.): IV49-54
12. Cooper GS, Virnig B, Klabunde CN, et al. Use of SEERMedicare data for measuring cancer surgery. Med Care 2002; 40 (8 Suppl.): IV43-8
13. Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002; 40 (8 Suppl.): IV104-17
14. Greene FL, Page DL, Fleming ID, et al. editors. AJCC cancer staging manual. 6th ed. Wickford: Lippincott Raven Publishers, 2002
15. Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 2006; 107 (11): 2581-2588 (Pubitemid 44845611)
16. Sundararajan V, Hershman D, Grann VR, et al. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol 2002; 20 (1): 173-178 (Pubitemid 34032609)
17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40 (5): 373-383
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45 (6): 613-619
19. Wedderburn RWM. Quasi-likelihood functions, generalized linear models, and the Gauss-Newton method. Biometrika 1974; 61: 439-447
20. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001; 20: 461-494
21. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998; 17: 283-295
22. Losina E, Barrett J, Baron JA, et al. Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003; 56 (6): 515-519
23. Newcomer R, Clay T, Luxenberg JS, et al. Misclassification and selection bias when identifying Alzheimer s disease solely from Medicare claims records. J Am Geriatr Soc 1999; 47 (2): 215-219